Pantothenate Kinase-associated Neurodegeneration
📧 Sign up to get email alerts when something new happens for Pantothenate Kinase-associated Neurodegeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: CoA-Z in Pantothenate Kinase-associated Neurodegeneration (PKAN) [NA]
Clinical trial evaluating CoA-Z in Pantothenate Kinase-associated Neurodegeneration has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Participants [Phase 3]
Phase 3 efficacy and safety study of fosmetpantotenate (RE-024) in Pantothenate Kinase-Associated Neurodegeneration (PKAN) was terminated.
-
CLINICAL_TRIALS trial_result · 2019-07-17Clinical Trial Update: Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration [Phase 3]
Phase 3 trial evaluating long-term deferiprone treatment in Pantothenate Kinase-Associated Neurodegeneration has completed with results post…
-
CLINICAL_TRIALS trial_result · 2019-05-23Clinical Trial Update: Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN) [Phase 3]
Phase 3 trial update on deferiprone for Pantothenate Kinase-associated Neurodegeneration (PKAN) with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2018-05-29Clinical Trial Update: Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)
Clinical trial evaluating brain perfusion for Pantothenate Kinase-associated Neurodegeneration (PKAN) has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.